Cite
Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium.
MLA
Brunner, Fabian J., et al. “Application of Non-HDL Cholesterol for Population-Based Cardiovascular Risk Stratification: Results from the Multinational Cardiovascular Risk Consortium.” Lancet, vol. 395, no. 10215, Dec. 2019, pp. 2173–83. EBSCOhost, https://doi.org/10.1016/S0140-6736(19)32519-X.
APA
Brunner, F. J., Waldeyer, C., Ojeda, F., Salomaa, V., Kee, F., Sans, S., Thorand, B., Giampaoli, S., Brambilla, P., Tunstall-Pedoe, H., Moitry, M., Iacoviello, L., Veronesi, G., Grassi, G., Mathiesen, E. B., Söderberg, S., Linneberg, A., Brenner, H., Amouyel, P., & Ferrières, J. (2019). Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium. Lancet, 395(10215), 2173–2183. https://doi.org/10.1016/S0140-6736(19)32519-X
Chicago
Brunner, Fabian J, Christoph Waldeyer, Francisco Ojeda, Veikko Salomaa, Frank Kee, Susana Sans, Barbara Thorand, et al. 2019. “Application of Non-HDL Cholesterol for Population-Based Cardiovascular Risk Stratification: Results from the Multinational Cardiovascular Risk Consortium.” Lancet 395 (10215): 2173–83. doi:10.1016/S0140-6736(19)32519-X.